From Rapid Progression to Long-Lasting Complete Response: A Wide Range of Ripretinib Activity for Metastatic GIST—A Real-World Cohort
Hanna T. Frumin Edri, Walid Shalata, Ilia Berezhnov, Tanzila Tairov et autres
0 citationsMedical Sciences
Gali Perl
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
40Publications signalées
300Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsGastric Cancer Management and OutcomesRadiomics and Machine Learning in Medical ImagingHepatocellular Carcinoma Treatment and Prognosis
Publications récentes
Clinical Applications of Tissue-Free Molecular Residual Disease (MRD) in Colorectal Cancer—Real-World Utilization and Case Series in Asian and Middle Eastern Patients
Yao‐Yu Hsieh, Viraj Lavingia, Gali Perl, Ching-Tso Chen et autres
0 citationsInternational Journal of Translational Medicine
731MO Telisotuzumab adizutecan (ABBV-400; Temab-A) in combination with bevacizumab (Bev) vs standard of care (SOC) in patients (pts) with 3L+ colorectal cancer (CRC): Dose expansion results of a phase I study
Michael Cecchini, Marcia Cruz‐Correa, Seung Woo Han, Kanwal Pratap Singh Raghav et autres
3 citationsAnnals of Oncology
Early prediction of histopathological response of locally advanced rectal cancer after 1 week of preoperative radiochemotherapy using 18FDG PET-CT imaging: a prospective clinical validation study
Yulia Kundel, Zoya Cohen, Noa Gordon, Aarón Sulkes et autres
2 citationsRadiation Oncology
Israel’s First Port-Based Hepatic Artery Infusion Program: Early Outcomes in Colorectal Liver Metastases
Roy Apel, Omri Sulimani, Gali Perl, Chen Abitbol et autres
2 citationsAnnals of Surgical Oncology
225P Updated results and first biomarker analysis of a phase II trial combining nivolumab (nivo) and total neoadjuvant treatment (TNT) for locally advanced rectal cancer (LARC) (CA209-8M4)
B. Brenner, Gali Perl, A. Rosenberg Ayal, M. Cohavi et autres
0 citationsAnnals of Oncology
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
Jin Li, M. Fernández, Felipe Reyes-Cosmelli, Yamilé Peña et autres
22 citationsJournal of Clinical Oncology
Reservoir-Less Ports for Hepatic Arterial Infusion
Yael Berger, Gali Perl, Eran Sadot
1 citation
Postoperative positron emission tomography–computed tomography (PET-CT) in patients (Pts) with pathological stage III colon cancer (CC): Results from the first prospective validation study.
Baruch Brenner, A.J. Rosenberg, Tzippy Shochat, Noa Gordon et autres
0 citationsJournal of Clinical Oncology
248P Preliminary results from CA209-8M4: A phase II trial evaluating the addition of nivolumab (nivo) to total neoadjuvant treatment (TNT) for locally advanced rectal cancer (LARC)
Benjamin Brenner, Gali Perl, A. Rosenberg Ayal, Tamar Shalmon et autres
3 citationsAnnals of Oncology
Hepatic parenchymal disease as a novel prognostic factor for colorectal liver metastasis
O. Wasser, A. Tobar, Yitzhak Berger, R. Naamana et autres
0 citationsHPB
Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy
Omer Gal, Ron Lewin, Gali Perl, Olga Ulitzky et autres
0 citationsJournal of Cancer Research and Therapeutics
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.